Cite

HARVARD Citation

    Shi, W. et al. (n.d.). CLRM-09 FIRST-LINE Tumor TREATING FIELDS (200 KHZ) THERAPY FOR NEWLY-DIAGNOSED GLIOBLASTOMA: THE PHASE 3 TRIDENT TRIAL (EF-32). Neuro-oncology advances. pp. i7-i8. [Online]. 
  
Back to record